SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-173878
Filing Date
2023-06-23
Accepted
2023-06-23 16:41:01
Documents
17
Period of Report
2023-06-22
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d501529d8k.htm   iXBRL 8-K 31259
2 EX-1.1 d501529dex11.htm EX-1.1 272124
3 EX-5.1 d501529dex51.htm EX-5.1 11698
4 EX-10.1 d501529dex101.htm EX-10.1 60386
8 GRAPHIC g501529g0623053024141.jpg GRAPHIC 3252
9 GRAPHIC g501529g0623053024361.jpg GRAPHIC 1414
  Complete submission text file 0001193125-23-173878.txt   598834

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA igms-20230622.xsd EX-101.SCH 2836
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE igms-20230622_lab.xml EX-101.LAB 17979
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE igms-20230622_pre.xml EX-101.PRE 11249
11 EXTRACTED XBRL INSTANCE DOCUMENT d501529d8k_htm.xml XML 3351
Mailing Address 325 E MIDDLEFIELD ROAD MOUNTAIN VIEW CA 94043
Business Address 325 E MIDDLEFIELD ROAD MOUNTAIN VIEW CA 94043 650-965-7873
IGM Biosciences, Inc. (Filer) CIK: 0001496323 (see all company filings)

IRS No.: 770349194 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39045 | Film No.: 231038329
SIC: 2834 Pharmaceutical Preparations